Patrizia Natale

Patrizia Natale

Auto-generated profile, based on publicly available information

Patrizia Natale

Sydney School of Public Health; The University of Sydney; Sydney Australia

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 September 2024 in Diabetes/Metabolism Research and Reviews
Verified
Journal Article
Open access
SMSergio Di Molfetta
Sergio Di Molfetta
LGLudovico Di Gioia
Ludovico Di Gioia
ICIrene Caruso
Irene Caruso
Angelo CignarelliAngelo Cignarelli
Angelo Cignarelli
SGSuetonia C. Green
Suetonia C. Green
Francesco GiorginoFrancesco Giorgino
Francesco Giorgino
Aims: To compare the efficacy and safety of different hybrid closed loop (HCL) systems in people with diabetes through a network meta‐analysis.Methods: We searched MEDLINE, EMBASE, CENTRAL and PubMed for randomised clinical trials (RCTs) enrolling children, adolescents and/or adults with type 1 or type 2 diabetes, evaluating Minimed 670G, Minimed 780G, Control‐IQ, CamAPS Fx, DBLG‐1, DBLHU, and Omnipod 5 HCL systems against other types of insulin therapy, and reporting time in target range (TIR) as outcome.Results: A total of 28 RCTs, all enrolling people with type 1 diabetes, were included. HCL systems significantly increased TIR compared with subcutaneous insulin therapy without continuous glucose monitoring (SIT). Minimed 780G achieved the highest TIR ahead of Control IQ (mean difference (MD) 5.1%, 95% confidence interval (95% CI) [0.68; 9.52], low certainty), Minimed 670G (MD 7.48%, 95% CI [4.27; 10.7], moderate certainty), CamAPS Fx (MD 8.94%, 95% CI [4.35; 13.54], low certainty), and DBLG1 (MD 10.69%, 95% CI [5.73; 15.65], low certainty). All HCL systems decreased time below target range, with DBLG1 (MD −3.69%, 95% CI [−5.2; −2.19], high certainty), Minimed 670G (MD −2.9%, 95% CI [−3.77; −2.04], moderate certainty) and Minimed 780G (MD −2.79%, 95% CI [−3.94; −1.64], high certainty) exhibiting the largest reductions compared to SIT. The risk of severe hypoglycaemia and diabetic ketoacidosis was similar to other types of insulin therapy.Conclusions: We show a hierarchy of efficacy among the different HCL systems in people with type 1 diabetes, thus providing support to clinical decision‐making.Trial Registration: PROSPERO CRD42023453717

1 June 2021 in Journal of Clinical Epidemiology
Verified
Journal Article
Closed access
PNPatrizia Natale
Patrizia Natale
VSValeria Saglimbene
Valeria Saglimbene
MRMarinella Ruospo
Marinella Ruospo
AGAndrea Matus Gonzalez
Andrea Matus Gonzalez
GSGiovanni Fm Strippoli
Giovanni Fm Strippoli
ATAllison Tong
Allison Tong

8 August 2023 in Journal of Diabetes
Verified
Journal Article
Open access
PNPatrizia Natale
Patrizia Natale
SCSharon Chen
Sharon Chen
CCClara K. Chow
Clara K. Chow
NCNgai Wah Cheung
Ngai Wah Cheung
DMDavid Martinez‐Martin
David Martinez‐Martin
AJAllison Jaure
Allison Jaure
Aims: Blood glucose control is central to the management of diabetes, and continuous glucose monitoring (CGM) improves glycemic control. We aimed to describe the perspectives of people with diabetes using CGM.Materials and methods: We performed a systematic review of qualitative studies.Results: Fifty‐four studies involving 1845 participants were included. Six themes were identified: gaining control and convenience (reducing pain and time, safeguarding against complications, achieving stricter glucose levels, and sharing responsibility with family); motivating self‐management (fostering ownership, and increasing awareness of glycemic control); providing reassurance and freedom (attaining peace of mind, and restoring social participation); developing confidence (encouraged by the endorsement of others, gaining operational skills, customizing settings for ease of use, and trust in the device); burdened with device complexities (bewildered by unfamiliar technology, reluctant to rely on algorithms, overwhelmed by data, frustrated with malfunctioning and inaccuracy, distressed by alerts, and bulkiness of machines interfering with lifestyle); and excluded by barriers to access (constrained by cost, lack of suppliers).Conclusions: CGM can improve self‐management and confidence in patients managing diabetes. However, the technical issues, uncertainty in readings, and cost may limit the uptake. Education and training from the health professionals may help to reduce the practical and psychological burden for better patient outcomes.

21 May 2024 in Cochrane Database of Systematic Reviews
Verified
Journal Article
Closed access
PDF file
PNPatrizia Natale
Patrizia Natale
DTDavid J Tunnicliffe
David J Tunnicliffe
TTTadashi Toyama
Tadashi Toyama
SPSuetonia C Palmer
Suetonia C Palmer
VSValeria M Saglimbene
Valeria M Saglimbene
GSGiovanni Fm Strippoli
Giovanni Fm Strippoli

25 February 2023 in American Journal of Hypertension
Verified
Journal Article
Open access
PDF file
PNPatrizia Natale
Patrizia Natale
JNJia Yi Ni
Jia Yi Ni
DMDavid Martinez Martin
David Martinez Martin
AKAyano Kelly
Ayano Kelly
CCClara Chow
Clara Chow
AJAllison Jaure
Allison Jaure
Background: Self-monitoring of blood pressure is a key strategy in managing hypertension but may be challenging and burdensome for patients. The aim of the study was to describe the perspectives and experiences of self-monitoring of blood pressure in patients with hypertension. Methods: MEDLINE, Embase, PsycINFO, and CINAHL were searched from database inception to March 2022. We used thematic synthesis to analyze the data. Results: Thirty-five studies involving 872 patients aged 18–95 years were included. Four themes were identified: enabling autonomy and empowerment of own health (allowing access to comprehensive and accurate data, bolstering motivation for lifestyle changes, encouraging diligence in medication taking, gaining interest in self-management, and increasing awareness of health status); providing reassurance and convenience (instilling a sense of security, readiness for troubleshooting, and reducing the frequency of clinical appointments); triggering confusion and stress (anxiety and panic over “bad” numbers, constant reminder of illness identity, disregarded by clinicians, lack of confidence in interpreting and responding to results, redundancy of continuous monitoring, and uncertainties around targets and frequency of measures, concerns of unreliability); financial and operational burden of device (vulnerability preventing use, or unsustainable cost). Conclusions: Inadequate knowledge about the benefits of lowering blood pressure, home blood pressure monitoring, blood pressure goals, and interpretation of blood pressure values, limited access to home blood pressure monitoring devices, and psychological burden with home blood pressure monitoring limit home blood pressure monitoring.

31 August 2023 in Cochrane Database of Systematic Reviews
Verified
Journal Article
Closed access
PDF file
PNPatrizia Natale
Patrizia Natale
AJAngela Ju
Angela Ju
GSGiovanni Fm Strippoli
Giovanni Fm Strippoli
JCJonathan C Craig
Jonathan C Craig
VSValeria M Saglimbene
Valeria M Saglimbene
AJAllison Jaure
Allison Jaure